Introduction

56
The first evidence-based report of cortisol level rises in multiple sclerosis (MS) 57 together with observed yawning is presented as a potential new diagnostic indicator 58 of signs associated with the onset of MS. 59
MS is a chronic debilitating condition that is progressive and affects the fatty 60 tissue sheath surrounding nerves. Incomplete innervation due to loss of the myelin 61 sheath is considered to be responsible for uncoordinated movements (1) . Brain 62 temperature fluctuations are seen in people with MS together with symptoms of 63 fatigue and especially when carrying out mentally or physically demanding tasks.
These are also associated with excessive yawning (2-3). Yet the cause of fatigue in 65 MS is not fully understood. 66
Attempts to clarify brain recruitment during fatigue in MS has revealed 67 involvement of the dorsolateral prefrontal cortex, , inferior parietal cortex, anterior 68 cingulate cortex and the thalamus (4). 69
Fatigue in MS has been investigated using variations in inducing fatigue 70 together with MRI scans to determine functional areas of brain activation. For 71 example, Thompson et al. (5) discovered that cortisol levels were found to be higher 72 during mental versus motor (physical) tasks. Recruitment of brainstem and 73 hypothalamus regions, important in cortisol activity, was affected differently (Fig 1) . 74 At low cortisol levels, mental task participants had less activity in the 80 hypothalamus than their physical task counterparts (Fig 2) . When cortisol levels 81 were higher, wider spread recruitment of both the hypothalamus and brainstem was 82 observed in the mental task participants, and for the physical task participants, the 83 spread was at comparative low levels of cortisol. 84 The authors concluded that cortisol is implicated in these brain regions and 89 that brain region recruitment is likely to be dependent upon factors such as 90 perception of stress in the task. It is likely that the mental tasks were perceived more 91 stressful than the physical tasks and therefore required higher cortisol levels to 92 promote wider spread brain region activity. 93
The hormone cortisol has been associated with yawning and fatigue and 94 described in the Thompson Cortisol Hypothesis (6). Threshold level rises of cortisol 95 appear to trigger the yawn which is proposed to be part of a complex mechanism for 96 lowering brain temperature (7). Brain temperature rises dramatically in people with 97 MS (8) and it has been proposed that cortisol is able to regulate brain temperature 98 because of its role within the hypothalamus-pituitary-adrenal (HPA-axis) (9), even 99 in the foetus and in young babies (10). 100
Secretion of cortisol is controlled by three inter-communicating regions of the 101 brain: hypothalamus, pituitary and adrenal glands. During low levels of cortisol in 102 the blood, the hypothalamus releases corticotrophin-releasing hormone causing the 103 pituitary gland to secrete adrenocorticotropic hormone into the bloodstream. High 104 levels of adrenocorticotropic hormone are detected in the adrenal glands which 105 stimulate the secretion of cortisol, causing blood levels of cortisol to rise. As the 106 cortisol levels rise, they start to block the release of corticotrophin-releasing 107 hormone from the hypothalamus and adrenocorticotropic hormone from the 108 pituitary (7). As a result, the adrenocorticotropic hormone levels start to fall 109 resulting in a fall in cortisol levels. This mechanism is known as a negative 110 feedback loop. 111
Cortisol has been noted during exposure to stressful events and may even be 112 modulated by contagious yawning (11). Yawning has also been observed to reduce 113 facial temperature in rats (12) but substantive evidence of brain cooling in humans 114 has been elusive to date. 115 Cortisol-specific receptors on the motor end plates would give rise to muscle 138 movements in the arm.
In stroke patients, cortisol levels may be inadequately detected and due to 140 incomplete innervation, the brainstem may fail to act on changes in cortisol levels to 141 prevent arm movement resulting in the observed parakinesia brachialis oscitans 142 seen in brainstem ischaemic patients (20-21). Whilst it is accepted that hormones 143 work within a system that comprises other hormones and complex neural circuitry, 144 it is often through direct observation that pathways can be understood. One-hundred-and-seventeen volunteers were recruited to the study. Eighty-156 four healthy volunteers (30 male, 54 female) aged between 18-69 years recruited 157 from students and the research volunteer pool at Bournemouth University using the 158 computerised recruitment system (SONA), and Facebook. Two of these participants 159 were subsequently excluded from data analyses due to the analytical laboratory 160 receiving two sets of dry saliva samples. 161
A further 33 volunteers (12 male, 21 female) who had a diagnosis of multiple 162 sclerosis were recruited from attendees of the Multiple Sclerosis SocietyBournemouth Branch and were aged between 34-70 years). All participants were 164
properly consented according to code of conduct and research guidelines. Exclusion 165 criteria was: chronic fatigue, congestive heart disorder, diabetes, fibromyalgia, heart 166 condition, high blood pressure, history of stress, psychiatric disorder, hormone 167 replacement therapy, renal problems, respiratory disorder, stroke, and multiple 168 sclerosis (except for the multiple sclerosis participants). The Hospital Anxiety and Depression Scale (HADS) (27) 
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The mean age of the healthy participants was 28 years compared with 57 205 years for the MS participants. There were no significant differences between groups 206 in terms of HADS anxiety and depression scores and GHQ28 scores. Normative 207 data for saliva cortisol is known, and lies within the following ranges: (i) Morning 208 collection is 3.7 -9.5 nanograms (one billionth of a gram or 10 -9 ) per millilitre of 209 saliva; (ii) Noon collection is 1.2 -3.0 nanograms per millilitre; (iii) Evening 210 collection is 0.6 -1.9 nanograms per millilitre. 211
For the healthy participants, there was no significant difference (p<.106) 212 between cortisol sample 1 and 2 for the non-yawners. For the participants with MS, 213 there was also no significant difference (p<.183) for the non-yawners (Tables 1 and  214 2). 215 
221
However, significant difference (p<.007) was found between cortisol sample 1 222 and 2 in the healthy participants; and in the MS participants, there was a greater 223 significant difference of p<.003 (Tables 3 and 4) . Comparison between healthy participants and MS participants revealed 242 significant difference (p<.042) between their second cortisol sample ( Table 5)  243 suggesting that the level of cortisol in those with MS is significantly different. 244
However, in the yawners, there was no significant difference (p<.862) between the 245 two groups (Table 6 ). This may indicate that changes in cortisol levels are similar in 246 both groups but actual levels of cortisol are significantly different and therefore 247 worthy of further investigation. 248 There are several interesting findings of this study. Of those participants who 257 did not yawn, the cortisol samples at rest and then at the end of stimuli presentations 258 was not significantly different within each group of participants. This is perhaps not 259 surprising since it is known that cortisol levels rise during episodes of stress, 260 whether perceived to be mentally fatiguing or if they are physically demanding. It 261 may be that for those who did not yawn, the tasks were not demanding in mental or 262 physical terms. 263
It is interesting that those participants with MS who did not yawn also had no 264 significant difference in their cortisol levels which tends to suggest that, in the 265 absence of yawning, cortisol levels in these participants did not significantly change 266 by the end of the testing session. 267
Perhaps of more scientific interest is the finding that participants who yawned 268 had elevated cortisol levels. Previous studies by the research team have found that 269 in healthy participants who yawn their cortisol levels rise significantly (10,23). 270
People who have MS often become fatigued and yawning are often observed as a 271 common symptom of MS (8). Therefore, it is of note that in those MS participants 272 who did yawn during the stimuli presentations, their cortisol levels significantly 273 raised in levels greater than their resting levels. It is also of note that not all of the 274 participants yawned; this may be because their symptoms of MS were not identical 275 to those who did yawn. Alternatively, it may be due to threshold levels of cortisol 276 not being reached, as compared with healthy participants who did not yawn. 277
It is proposed that people with threshold levels of cortisol yawn, whether they 278 have MS or not; however, changes in cortisol levels after yawning were not 279 significantly different between the healthy and MS participants although there was a 280 significant difference between the groups in their second saliva sample for the non-281 yawners. This is interesting because significant difference in levels between healthy 282 participants and those with MS might suggest that cortisol levels are important insymptoms. It will be interesting to see if the effects of these cortisol levels are 285 directly correlated to lowering brain temperature since yawning seems to lower 286 temperature. 287
These findings tend to support the Thompson Cortisol Hypothesis (1,6) that 288
proposes yawning occurs when threshold levels of cortisol are reached in order to 289 reduce brain temperature. This is shown in both the healthy and MS participants. 290
Communication with the motor cortex via cortisol-specific receptors may also 291 explain how involuntary movement of the arm in brainstem ischaemic patients can 292 occur partly due to incomplete innervation and irregulation of cortisol within the 293 HPA-axis which has been extensively discussed elsewhere (1, 20, 21, 30) . 294
The picture in neurological and biological diseases is complex because they 295 present with a range of symptoms and severity. However, cortisol features in many 296 disorders as well as the body's natural stress hormone. Hence it is suggested that it 297 may provide an important key to our understanding of the way many neurological 298 disorders are linked. It may also provide scientists and practitioners in the near 299 future with a potential identifier or even diagnostic indicator of underlying and 300 untoward neurological disease systems including MS. 301
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